These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 14738453)

  • 1. Blocking B7 and CD40 co-stimulatory molecules decreases antiviral T cell activity.
    Vermeiren J; Ceuppens JL; Haegel-Kronenberger H; De Boer M; Boon L; Van Gool SW
    Clin Exp Immunol; 2004 Feb; 135(2):253-8. PubMed ID: 14738453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
    Costello RT; Mallet F; Sainty D; Maraninchi D; Gastaut JA; Olive D
    Eur J Immunol; 1998 Jan; 28(1):90-103. PubMed ID: 9485189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential graft-versus-leukaemia effect by CD28 and CD40 co-stimulatory blockade after graft-versus-host disease prophylaxis.
    Ohata J; Sakurai J; Saito K; Tani K; Asano S; Azuma M
    Clin Exp Immunol; 2002 Jul; 129(1):61-8. PubMed ID: 12100023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential requirements for co-stimulatory signals from B7 family members by resting versus recently activated memory T cells towards soluble recall antigens.
    Yi-qun Z; Joost van Neerven RJ; Kasran A; de Boer M; Ceuppens JL
    Int Immunol; 1996 Jan; 8(1):37-44. PubMed ID: 8671587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A T cell lymphoma can provide potent co-stimulatory effects to T cells that are not mediated by B7-1, B7-2, CD40, HSA or CD70.
    Nieland JD; Kruisbeek AM
    Int Immunol; 1995 Nov; 7(11):1827-38. PubMed ID: 8580081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production.
    Van Gool SW; Vermeiren J; Rafiq K; Lorr K; de Boer M; Ceuppens JL
    Eur J Immunol; 1999 Aug; 29(8):2367-75. PubMed ID: 10458748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FcR cross-linking on monocytes results in impaired T cell stimulatory capacity.
    Barcy S; Wettendorff M; Leo O; Urbain J; Kruger M; Ceuppens JL; de Boer M
    Int Immunol; 1995 Feb; 7(2):179-89. PubMed ID: 7537534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression and function of CD80 (B7-1) and CD86 (B7-2) on human peripheral blood monocytes.
    Fleischer J; Soeth E; Reiling N; Grage-Griebenow E; Flad HD; Ernst M
    Immunology; 1996 Dec; 89(4):592-8. PubMed ID: 9014827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B7-CD28 interaction is a late acting co-stimulatory signal for human T cell responses.
    Zhang YQ; Joost van Neerven RJ; Van Gool SW; Coorevits L; de Boer M; Ceuppens JL
    Int Immunol; 1997 Aug; 9(8):1095-102. PubMed ID: 9263006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel bispecific antihuman CD40/CD86 fusion protein with t-cell tolerizing potential.
    Koenen HJ; den Hartog MT; Heerkens S; Fasse E; Ortiz-Buijsse A; van Neerven RJ; Simons PJ; Joosten I; Boon L
    Transplantation; 2004 Nov; 78(10):1429-38. PubMed ID: 15599306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoids inhibit activation-dependent expression of costimulatory molecule B7-1 in human monocytes.
    Girndt M; Sester U; Kaul H; Hünger F; Köhler H
    Transplantation; 1998 Aug; 66(3):370-5. PubMed ID: 9721807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of B7-1 (CD80) and B7-2 (CD86) costimulatory molecules and dendritic cells on the immune response in leprosy.
    Santos DO; Santos SL; Esquenazi D; Nery JA; Defruyt M; Lorré K; Van Heuverswyn H
    Nihon Hansenbyo Gakkai Zasshi; 2001 Feb; 70(1):15-24. PubMed ID: 11244783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of B7 co-stimulatory molecules by astrocytes correlates with T cell activation and cytokine production.
    Soos JM; Ashley TA; Morrow J; Patarroyo JC; Szente BE; Zamvil SS
    Int Immunol; 1999 Jul; 11(7):1169-79. PubMed ID: 10383950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin's lymphomas.
    Chaperot L; Plumas J; Jacob MC; Bost F; Molens JP; Sotto JJ; Bensa JC
    Exp Hematol; 1999 Mar; 27(3):479-88. PubMed ID: 10089910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of CD86 and CD40 induces alloantigen-specific immunoregulatory T cells that remain anergic even after reversal of hyporesponsiveness.
    Koenen HJ; Joosten I
    Blood; 2000 May; 95(10):3153-61. PubMed ID: 10807782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD40 stimulation in vivo does not inhibit CD4+ T cell tolerance to soluble antigens.
    Sun J; Van Houten N
    Immunol Lett; 2002 Nov; 84(2):125-32. PubMed ID: 12270549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human T cell activation by costimulatory signal-deficient allogeneic cells induces inducible costimulator-expressing anergic T cells with regulatory cell activity.
    Vermeiren J; Ceuppens JL; Van Ghelue M; Witters P; Bullens D; Mages HW; Kroczek RA; Van Gool SW
    J Immunol; 2004 May; 172(9):5371-8. PubMed ID: 15100277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD80, CD86 and CD40 provide accessory signals in a multiple-step T-cell activation model.
    Van Gool SW; Vandenberghe P; de Boer M; Ceuppens JL
    Immunol Rev; 1996 Oct; 153():47-83. PubMed ID: 9010719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interference with CD28, CD80, CD86 or CD152 in collagen-induced arthritis. Limited role of IFN-gamma in anti-B7-mediated suppression of disease.
    Tellander AC; Pettersson U; Runström A; Andersson M; Michaëlsson E
    J Autoimmun; 2001 Aug; 17(1):39-50. PubMed ID: 11488636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and functional role of co-stimulatory molecules in CD40+IL-4-stimulated B cells from atopic and non-atopic donors.
    Oberwalleney G; Henz BM; Worm M
    Acta Derm Venereol; 2000; 80(4):287-91. PubMed ID: 11028864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.